Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma

With the increasing incidence and mortality of human hepatocellular carcinoma (HCC) worldwide, revealing innovative targets to improve therapeutic strategies is crucial for prolonging the lives of patients. To identify innovative targets, we conducted a comprehensive comparative transcriptome analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Chun-Ming, Lin, Kuen-Tyng, Shen, Roger, Gu, De-Leung, Lee, Szu-Shuo, Su, Wen-Hui, Jou, Yuh-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024375/
https://www.ncbi.nlm.nih.gov/pubmed/35495118
http://dx.doi.org/10.1016/j.csbj.2022.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024375/
https://www.ncbi.nlm.nih.gov/pubmed/35495118
http://dx.doi.org/10.1016/j.csbj.2022.04.008

Ejemplares similares